ARTICLE | Clinical News
CardiAMP: Ph III CardiAMP Heart Failure started
January 4, 2017 10:19 PM UTC
BioCardia began the double-blind, sham-controlled, U.S. Phase III CardiAMP Heart Failure trial to evaluate CardiAMP in up to 260 patients....
BCIQ Company Profiles